Golubieski John 4
4 · Axsome Therapeutics, Inc. · Filed Aug 8, 2017
Insider Transaction Report
Form 4
Golubieski John
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-08-04+132,000→ 132,000 totalExercise: $5.90Exp: 2027-08-04→ Common Stock (132,000 underlying)
Footnotes (1)
- [F1]The option will vest in equal annual installments over four years such that the option will be fully vested on August 4, 2021.